BMO Capital maintains Amgen stock rating citing Tavneos concerns

BMO Capital maintains Amgen stock rating citing Tavneos concerns  Investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.